David Galton
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Lipid metabolism and disorders
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Diabetes Treatment and Management 3
-
- Lipid metabolism and disorders 6
- Co-authors
- J. Stocks (9 shared papers)Anna M. Kessling (2 shared papers)G. Holdsworth (1 shared paper)Steve E. Humphries (1 shared paper)Philippa J. Talmud (1 shared paper)Peter Carlsson (1 shared paper)Gunnar Bjursell (1 shared paper)V. Wynn (1 shared paper)
- Journals
- Human Genetics (3 papers)Nucleic Acids Research (3 papers)Hormone and Metabolic Research (2 papers)QJM (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
David Galton
18 papers receiving 421 citations
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 229
- Cardiology and Cardiovascular Medicine 106
- Surgery 201
- Cancer Research 52
- Genetics 98
Countries citing papers authored by David Galton
This map shows the geographic impact of David Galton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Galton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Galton more than expected).
Fields of papers citing papers by David Galton
This network shows the impact of papers produced by David Galton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Galton. The network helps show where David Galton may publish in the future.
Co-authors
The 25 scholars most cited alongside David Galton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 147 | |
| 2 | 1986 | 52 | |
| 3 | 1979 | 42 | |
| 4 | 1987 | 36 | |
| 5 | Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia. | 1987 | 34 |
| 6 | 1988 | 21 | |
| 7 | 1985 | 20 | |
| 8 | 1986 | 19 | |
| 9 | 1974 | 15 | |
| 10 | 1988 | 12 | |
| 11 | 1993 | 11 | |
| 12 | 2009 | 9 | |
| 13 | 1966 | 7 | |
| 14 | 2000 | 6 | |
| 15 | 1974 | 4 | |
| 16 | 1989 | 2 | |
| 17 | 2000 | 1 | |
| 18 | 2009 | 1 | |
| 19 | 1987 | 1 |
About David Galton
David Galton is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Genetics and Surgery, having authored 19 papers that have together received 440 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Diabetes Treatment and Management (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Adipose Tissue and Metabolism (3 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (229 citations), Cardiology and Cardiovascular Medicine (106 citations), Surgery (201 citations), Cancer Research (52 citations) and Genetics (98 citations). David Galton has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include J. Stocks, Anna M. Kessling, G. Holdsworth, Steve E. Humphries, Philippa J. Talmud, Peter Carlsson, Gunnar Bjursell, V. Wynn, Heather Kirk and A. Rees. Their work appears in journals such as Human Genetics, Nucleic Acids Research, Hormone and Metabolic Research, QJM and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.